Health Economics

The Health Economics team is predominantly working on economic evaluations of health interventions for cancer populations and the personal financial burdens of cancer survivors.  The health economic program spans the full range of cancer care from prevention, early detection, treatment, survivorship and palliative care. Currently, projects cover the areas of supportive care interventions (prostate, pancreatic cancer), genomic sequencing (myeloid blood cancers, breast/ovarian cancer, cancers of unknown primary, lung), skin cancer prevention and targeted screening and exercise interventions (ovarian, breast cancers). The team is also interested in the social and economic consequences of cancer and research that addresses the importance of reducing health inequities.

CURRENT RESEARCH

  • evaluation of clinical genomics projects involving:
    • whole genome sequencing of serious bacterial infections for hospitalised patients to prevent or delay hospital outbreaks
    • panel testing of patients with myeloid blood cancers
    • whole exome sequencing for patients with refractory epilepsy
    • genomic sequencing for relatives of patients with ovarian cancer (TRACEBACK)
    • genomic sequencing for patients with cancers of unknown primary
  • economic costs of skin cancers, targeted screening and prevention
  • nurse practitioner endoscopy versus medical endoscopy – comparison of quality, effectiveness and economic impacts
  • decision support intervention for men with early stage prostate cancer
  • telehealth delivered psychosocial support for patients with brain tumours
  • teledermatology interventions for patients at extreme risk of melanoma
  • risk-stratified screening for patients at high risk for liver cancer
  • economics of organ transplantation and skin cancers
  • economic impacts of regulation to limit indoor tanning behaviours to prevent skin cancers
  • Cancer
  • Infectious diseases

Staff

  • Thomas Elliot, Senior Research Assistant
  • Astrid Rodriguez-Acevedo, Research Officer
  • Jason Zischke, PhD student
  • Ming Ho, PhD student
  • Michelle Roets, PhD student

Internal Collaborators

External Collaborators

  • Associate Professor Penelope Schofield, University of Swinburne
  • Dr Katharina Merollini, University of Sunshine Coast
  • Professor David Watson, Surgeon, Flinders Medical Centre
  • Associate Professor David Wyld, Royal Brisbane and Women’s Hospital
  • Professor Raymond Chan, Queensland University of Technology
  • Professor Sandi Hayes, Queensland University of Technology
  • Dr Amanda Fox, Queensland University of Technology
  • Professor Richard Tothill, Peter MacCallum Cancer Centre
  • Professor Deborah Schofield, Macquarie University
  • Professor Elizabeth Eakin, The University of Queensland
  • Professor Peter Soyer, The University of Queensland
  • Professor Monika Janda, The University of Queensland
  • Professor David Paterson, The University of Queensland
  • Dr Patrick Harris, The University of Queensland
  • Associate Professor Lata Vadlamudi, The University of Queensland
  • Professor Tamara Ownsworth, Griffith University
  • NHMRC
  • MRFF
  • Queensland Genomics
  • Cancer Council Queensland